The Bone Cancer Research Trust's policy on working with pharmaceutical and medical device companies aims to provide clear principles and guidance about how we work with pharmaceutical companies and medical device companies to help achieve our aims and objectives.

Download the Bone Cancer Research Trust Pharmaceutical Policy (updated 2014, next review 2017)

For more information on this policy, contact us.

Further details about the support we receive from pharmaceutical and medical device companies are below.

If you work for a pharmaceutical company and would like to discuss how you could support us, please contact Mat Cottle, Head of Fundraising and Communications on 0113 258 5934.

Support received in 2014

  • Takeda £875 - For project input
  • Implantcast £1,500 - Patients and Supporters Conference
  • Takeda £5,000 - Research Strategy Meeting
  • Takeda £5,000 - Patients and Supporters Conference

Support received in 2013

  • None received

Support received in 2012

  • Takeda £2,500 - Patients and Supporters Conference

Support received in 2011

  • Takeda £5,000 - Patients and Supporters Conference

Support received in 2010

  • Takeda £5,000 - Patients and Supporters Conference